Plant enzymatic peptide and its use in inhibiting scars and preparing scar-inhibiting cosmetics

By preparing and applying 3-5 kDa plant enzymatic peptides, the technical challenge of inhibiting hypertrophic scars was solved, achieving the inhibition of proliferation and promotion of apoptosis of keloid fibroblasts, with a significant effect on inhibiting hypertrophic scars.

CN114480543BActive Publication Date: 2024-11-05HUAIAN WEIERMEI COSMETICS CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202210109700.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-01-29
Publication Date
2024-11-05
Estimated Expiration
2042-01-29

AI Technical Summary

Technical Problem

Existing technologies are insufficient to effectively inhibit the formation of hypertrophic scars, especially by inhibiting the proliferation of keloid fibroblasts and promoting their apoptosis.

Method used

Plant-derived enzymatic peptides were prepared by means of petroleum ether defatting, water extraction, enzymatic hydrolysis, and molecular weight cutoff to obtain 3-5 kDa enzymatic peptides, which were used to inhibit the proliferation of human keloid fibroblasts and promote their apoptosis.

Benefits of technology

Plant-derived enzymatic peptides significantly inhibited the proliferation of human keloid fibroblasts and promoted their apoptosis, thereby effectively inhibiting the formation of hypertrophic scars.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114480543B_ABST
    Figure CN114480543B_ABST
Patent Text Reader

Abstract

The present invention discloses a plant enzymatic peptide and its use in inhibiting scars and preparing scar-inhibiting cosmetics. The plant enzymatic peptide provided by the present invention can inhibit the proliferation of human keloid fibroblasts HKF, promote their apoptosis, and has the effect of inhibiting hypertrophic scars. Therefore, the plant enzymatic peptide can be further developed into cosmetics or medicines for inhibiting hypertrophic scars.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of cosmetics and relates to the development of active ingredients of cosmetics, and specifically relates to a plant enzymatic peptide and its use in inhibiting scars and preparing scar-inhibiting cosmetics. Background Art

[0002] Hypertrophic scar is a skin disease. Excessive proliferation and abnormal reduction of apoptosis of keloid fibroblasts are the key causes of hypertrophic scar formation. Hypertrophic scars usually develop during the healing process after deep trauma or burns, which not only cause functional impairment of the affected area, but also bring physical and psychological distress to patients.

[0003] Therefore, inhibiting the proliferation of keloid fibroblasts and promoting their apoptosis are the key to inhibiting hypertrophic scars. Summary of the invention

[0004] The present invention aims to provide a plant enzymatic peptide and its use in inhibiting scars and preparing scar-inhibiting cosmetics.

[0005] The technical solution of the present invention is as follows:

[0006] A plant enzymatic peptide is prepared by the following method:

[0007] Take the seeds of Salvia jasminoides, use petroleum ether with a boiling range of 60 to 90° C. to heat-reflux defatted seeds, collect the defatted seeds, evaporate the solvent, heat-extract with distilled water at pH=7.8, collect the distilled water extract, let it stand overnight, take the supernatant, centrifuge, collect the supernatant, adjust the pH to 5.2, centrifuge, collect the precipitate, re-dissolve with an appropriate amount of distilled water, dialyze, and freeze-dry to obtain total protein;

[0008] Take an appropriate amount of total protein and dissolve it in distilled water to prepare a protein solution, add papain for enzymolysis, and the enzymolysis conditions are: pH value = 6.5, enzymolysis temperature = 50°C, and enzymolysis time = 5 hours; immediately place it in a boiling water bath to heat and inactivate the enzyme after the enzymolysis is completed, cool the enzymolysis solution after the enzyme inactivation to room temperature, centrifuge, and freeze-dry the supernatant to obtain enzymolysis lyophilized powder;

[0009] The enzymatic lyophilized powder was dissolved in distilled water, passed through ultrafiltration membranes with molecular weight cutoffs of 5 kDa and 3 kDa in sequence, and enzymatic peptides of 3 to 5 kDa were retained, and freeze-dried to obtain plant enzymatic peptides.

[0010] Preferably, the temperature of the distilled water heating extraction is 60°C.

[0011] Preferably, the adjusting reagents for adjusting pH are 1 mol / L sodium hydroxide solution and 1 mol / L hydrochloric acid solution.

[0012] Preferably, the centrifugation condition during the total protein preparation process is 12000 r / min for 15 min.

[0013] Preferably, 2500 U of protease is added per gram of total protein.

[0014] Preferably, the enzymatic hydrolysate is centrifuged at 5000 r / min for 15 min.

[0015] The plant enzymatic peptide is used for preparing cosmetics for inhibiting hypertrophic scars.

[0016] Beneficial technical effects:

[0017] The plant enzymatic peptide provided by the present invention can inhibit the proliferation of human keloid fibroblasts HKF, promote their apoptosis, and has the effect of inhibiting hypertrophic scars. Therefore, the plant enzymatic peptide provided by the present invention can be further developed into cosmetics or medicines for inhibiting hypertrophic scars. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 These are the apoptosis images of human keloid fibroblasts HKF in each group using AnnexinV-FITC / PI double staining method. DETAILED DESCRIPTION

[0019] The essential contents of the present invention are described in detail below through specific embodiments, but the protection scope of the present invention is not limited thereto.

[0020] 1. Materials

[0021] The blue sage seeds are the seeds of blue sage (Salvia farinacea), which are dried and crushed for later use. Papain was purchased from Novozymes. Human keloid fibroblasts HKF were purchased from Shanghai Yaji Biotechnology Co., Ltd., with the brand of ATCC.

[0022] 2. Methods

[0023] 1. Preparation of plant enzymatic peptides

[0024] Take 1kg of blue sage seeds, add 5L of petroleum ether with a boiling range of 60-90℃, and heat reflux extract for 3.5h. Collect the defatted seeds, evaporate the solvent, add 5L of distilled water with pH=7.8 and heat extract for 3.5h, and the extraction temperature is 60℃. Measure and adjust the pH every 15min. The pH adjustment reagent is 1mol / L sodium hydroxide solution and 1mol / L hydrochloric acid solution (the same below). Collect the distilled water extract, let it stand overnight, take the supernatant, centrifuge at 12000r / min for 15min, collect the supernatant, and adjust the pH to 5.2. pH=5.2 is the isoelectric point of blue sage seed protein. Centrifuge the solution adjusted to the isoelectric point of the protein at 12000r / min for 15min, collect the precipitate, re-dissolve it with an appropriate amount of distilled water, dialyze for 72h, and freeze-dry to obtain 77g of total protein in blue sage seeds.

[0025] Take 10g of total protein and dissolve it in 200mL of distilled water to prepare a protein solution, add papain, the amount of protease added is 2500U / g substrate, the enzymatic hydrolysis conditions are: pH value = 6.5, enzymatic hydrolysis temperature = 50℃, enzymatic hydrolysis time = 5 hours. Immediately after the enzymatic hydrolysis, heat it in a boiling water bath for 15min to inactivate the enzyme. Cool the inactivated enzymatic hydrolyzate to room temperature, centrifuge it at 5000r / min for 15min, take the supernatant and freeze-dry it, and store the freeze-dried powder at 4℃.

[0026] The lyophilized powder was dissolved in distilled water. 1 g of lyophilized powder was added with 50 mL of distilled water and passed through ultrafiltration membranes with molecular weight cutoffs of 5 kDa and 3 kDa in sequence to retain enzymatic peptides of 3 to 5 kDa. The mixture was freeze-dried and stored at 4°C.

[0027] 2. Culture of human keloid fibroblasts HKF

[0028] Human keloid fibroblasts HKF were cultured in RPMI 1640 culture medium containing 10% fetal bovine serum and 1% double antibody in an incubator at 37°C, saturated humidity and 5% CO2.

[0029] 3. Cell proliferation ability detection (CCK-8 method)

[0030] HKF cells in logarithmic growth phase were digested with 0.25% trypsin, resuspended in RPMI1640 culture medium containing 10% fetal bovine serum and 1% double antibody, counted under a microscope, and inoculated in 96-well plates at 5000 cells / 100 μL culture medium per well. After culturing for 24 hours, 100 μL culture medium was added to the blank control group, and 100 μL culture medium containing 20 and 50 μg / mL enzymatic peptides (prepared as described above) was added to the enzymatic peptide group, and 5 replicate wells were set for each group. After culturing for 48 hours at 37°C, saturated humidity, and 5% CO2, 10 μL CCK-8 solution was added to each well, and the incubation continued for 4 hours. The absorbance (OD) value was read at a wavelength of 450 nm in an ELISA reader, and the cell inhibition rate was calculated. Inhibition rate (%) = (1-OD value of enzymatic peptide group / OD value of blank control group) × 100%.

[0031] 4. Cell apoptosis detection (flow cytometry)

[0032] HKF cells in logarithmic growth phase were obtained, digested with 0.25% trypsin, resuspended in RPMI1640 culture medium containing 10% fetal bovine serum and 1% double antibody, and counted under a microscope. 5×10 cells were counted per well. 5 Cells / 1mL were inoculated in 6-well plates. After culturing for 24 hours, 1mL of culture medium was added to the blank control group, and 1mL of culture medium containing 20 and 50μg / mL enzymatic peptides (prepared as described above) was added to the enzymatic peptide group. Two replicate wells were set up for each group. After culturing for 24 hours at 37°C, saturated humidity, and 5% CO2, the cells were collected, washed with PBS, and stained with AnnexinV-FITC / PI double staining method according to the instructions of the kit, incubated in the dark, and detected by flow cytometry.

[0033] 5. Statistical analysis

[0034] The data were expressed as mean ± SD, and the t test was used for comparison among the groups. P < 0.05 indicated a significant difference.

[0035] 3. Results

[0036] 1. Comparison of cell proliferation ability among groups

[0037] The inhibition rates of HKF cells in the 20 and 50 μg / mL enzymatic peptide groups were (22.7±4.5)% and (68.1±5.3)%, respectively. Different concentrations of enzymatic peptides significantly inhibited the proliferation of HKF cells, and the higher the concentration, the stronger the inhibitory effect.

[0038] 2. Comparison of cell apoptosis in each group

[0039] Figure 1The results of flow cytometry detection. In the apoptosis diagram of AnnexinV-FITC / PI double staining method, the cells in the (Annexin V-FITC)- / PI+ area are necrotic cells, the cells in the (Annexin V-FITC)+ / PI+ area are late apoptotic cells, the cells in the (Annexin V-FITC)+ / PI- area are early apoptotic cells, and the cells in the (AnnexinV-FITC)- / PI- area are living cells. Compared with the blank control group, the proportion of cells in the (AnnexinV-FITC)+ / PI+ area plus the cells in the (Annexin V-FITC)+ / PI- area in the 20 and 50μg / mL enzymatic peptide groups was significantly increased, and the higher the concentration, the greater the proportion of apoptotic cells.

[0040] The above examples show that the plant enzymatic peptides provided by the present invention can inhibit the proliferation of human keloid fibroblasts HKF, promote their apoptosis, and have the effect of inhibiting hypertrophic scars. Therefore, the plant enzymatic peptides provided by the present invention can be further developed into cosmetics or medicines for inhibiting hypertrophic scars.

Claims

1. A plant enzymatic peptide, characterized in that: Prepared by the following method: Take the seeds of Salvia jasminoides, use petroleum ether with a boiling range of 60-90°C for hot reflux defatting, collect the defatted seeds, evaporate the solvent, use distilled water with pH=7.8 for heating extraction at 60°C, collect the distilled water extract, let it stand overnight, take the supernatant, centrifuge, collect the supernatant, adjust the pH to 5.2, centrifuge, collect the precipitate, re-dissolve with an appropriate amount of distilled water, dialyze, and freeze-dry to obtain the total protein; The centrifugation conditions during the total protein preparation were all 12000 r / min for 15 min; Take an appropriate amount of total protein and dissolve it in distilled water to prepare a protein solution, add papain for enzymolysis, add 2500U papain for each gram of total protein, and the enzymolysis conditions are: pH value = 6.5, enzymolysis temperature = 50°C, and enzymolysis time = 5 hours; immediately place it in a boiling water bath to heat and inactivate the enzyme after the enzymolysis is completed, cool the enzymolysis solution after the enzyme inactivation to room temperature, centrifuge it at 5000r / min for 15 minutes, take the supernatant and freeze-dry it to obtain enzymolysis freeze-dried powder; The enzymatic lyophilized powder was dissolved in distilled water, passed through ultrafiltration membranes with molecular weight cutoffs of 5 kDa and 3 kDa in sequence, and the enzymatic peptides of 3-5 kDa were retained, and freeze-dried to obtain plant enzymatic peptides.

2. The plant enzymatic peptide according to claim 1, characterized in that: The adjusting reagents for adjusting pH are 1 mol / L sodium hydroxide solution and 1 mol / L hydrochloric acid solution.

3. Use of the plant enzymatic peptide according to claim 1 or 2 for preparing cosmetics for inhibiting hypertrophic scars.

Citation Information

Patent Citations

  • Traditional Chinese medicine composition for treating scar and preparation method thereof

    CN103735959A

  • Plant-derived polypeptide with anti-aging effect, face cream containing plant-derived polypeptide and preparation method of face cream

    CN112080543A

  • Composition for inhibiting growth or metastasis of keloids

    KR101346779B1

  • Use of a vegetal extract as an active agent in tissue re-epithelizing and cicatrizing processes

    US20200376064A1